Skip to content

The clinical role of BAFF and APRIL in the human pancreatic cancer.

The clinical role of BAFF and APRIL in the human pancreatic cancer. - Study of BAFF and APRIL in pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000008654
Enrollment
100
Registered
2012-08-09
Start date
2011-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Sponsors

Ehime University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who were taken a blood sample or pancreatic tissue by internal or surgical treatment.

Exclusion criteria

Exclusion criteria: Subjects who are considered that taking the samples will make worse their prognosis.

Design outcomes

Primary

MeasureTime frame
Clinical roles

Countries

Japan

Contacts

Public ContactMitsuhito Koizumi

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

koizumim08@gmail.com+81-89-960-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026